Physician profile
Tucker D Benjamin
NPI 1407122591
$2,150.62
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,277 · 2022: $313 · 2023: $302 · 2024: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,382.12 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $169.25 | 2022-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Seamguard Staple Line Reinforcement |
| Novo Nordisk INC | $122.33 | 2021-2023 | Wegovy |
| Medtronic, INC. | $104.70 | 2021-2023 | Signia |
| Hologic Sales and Service, LLC | $67.17 | 2024 | Coolseal Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $60.05 | 2022-2023 | Gattex |
| Pacira Pharmaceuticals Incorporated | $58.07 | 2023-2024 | Exparel |
| Integra Lifesciences Corporation | $45.00 | 2021 | |
| Heron Therapeutics, INC. | $29.20 | 2024 | Zynrelef |
| Echosens North America, INC. | $24.69 | 2024 | Fibroscan |
| Vertex Pharmaceuticals Incorporated | $23.38 | 2024 | |
| Endo Pharmaceuticals INC. | $19.37 | 2022 | |
| Lilly USA, LLC | $18.14 | 2024 | Zepbound |
| Solventum Corporation | $14.32 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Biogen, INC. | $12.83 | 2023 | Vumerity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tucker Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.